U.S. Markets open in 7 hrs 54 mins
  • S&P Futures

    4,456.25
    -18.50 (-0.41%)
     
  • Dow Futures

    34,605.00
    -11.00 (-0.03%)
     
  • Nasdaq Futures

    14,707.00
    -134.00 (-0.90%)
     
  • Russell 2000 Futures

    2,021.00
    -0.20 (-0.01%)
     
  • Crude Oil

    86.29
    -0.61 (-0.70%)
     
  • Gold

    1,840.70
    -1.90 (-0.10%)
     
  • Silver

    24.56
    -0.16 (-0.65%)
     
  • EUR/USD

    1.1330
    +0.0013 (+0.1133%)
     
  • 10-Yr Bond

    1.8330
    0.0000 (0.00%)
     
  • Vix

    25.59
    +1.74 (+7.30%)
     
  • GBP/USD

    1.3587
    -0.0013 (-0.0938%)
     
  • USD/JPY

    113.8500
    -0.2500 (-0.2191%)
     
  • BTC-USD

    38,787.18
    -3,240.28 (-7.71%)
     
  • CMC Crypto 200

    916.17
    -79.09 (-7.95%)
     
  • FTSE 100

    7,585.01
    -4.65 (-0.06%)
     
  • Nikkei 225

    27,522.26
    -250.64 (-0.90%)
     

Collegium Pharmaceutical's Earnings Outlook

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • COLL

On Thursday, February 25, Collegium Pharmaceutical (NASDAQ:COLL) will release its latest earnings report. Here is Benzinga's outlook for the company.

What Are Earnings, Net Income, And Earnings Per Share?

Earnings and especially earnings per share (EPS) are useful measures of a company's profitability. Total earnings, which is also referred to as net income, equals total revenue minus total expenses. EPS equals to net income divided by the number of shares outstanding.

Earnings And Revenue

Analysts expect Collegium Pharmaceutical earnings of $0.29 per share. Revenue will likely be around $77.41 million, according to the consensus estimate. Collegium Pharmaceutical's loss in the same period a year ago was $0.07 per share. Quarterly sales came in at $74.20 million.

What Are Analyst Estimates And Earnings Surprises, And Why Do They Matter?

Analysts who cover this company will publish forward-looking estimates of its revenue and EPS each quarter. Averaging together every EPS and revenue prediction that each analyst makes about a company in a quarter yields the "consensus estimates." A company posting earnings or revenue above or below the consensus estimate is known as an "earnings surprise" and may move the stock by a considerable margin.

View more earnings on COLL

The Wall Street estimate would represent a 514.29% increase in the company's earnings. Sales would be up 4.32% from the same quarter last year. Collegium Pharmaceutical's reported EPS has stacked up against analyst estimates in the past like this:

EPS Estimate

0.22

0.20

0.37

-0.10

EPS Actual

0.32

0.23

0.01

-0.07

Revenue Estimate

77.43 M

74.40 M

77.08 M

73.33 M

Revenue Actual

79.18 M

78.06 M

76.51 M

74.20 M

Stock Performance

Shares of Collegium Pharmaceutical were trading at $24.52 as of February 23. Over the last 52-week period, shares are up 15.31%. Given that these returns are generally positive, long-term shareholders can be satisfied going into this earnings release.

Do not be surprised to see the stock move on comments made during its conference call. Collegium Pharmaceutical is scheduled to hold the call at 16:30:00 ET and can be accessed here.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.